Twist Bioscience Corporation (TWST) Misses Q3 EPS by 71c ; Offers Guidance

Twist Bioscience Corporation (NASDAQ: TWST) reported Q3 EPS of ($1.47), $0.71 worse than the analyst estimate of ($0.76). Revenue for the quarter came in at $81.5 million versus the consensus estimate of $77.4 million.

GUIDANCE:

Twist Bioscience Corporation sees FY2024 revenue of $310-311 million, versus the consensus of $303.8 million.

Twist Bioscience Corporation sees Q4 2024 revenue of $82-83 million, versus the consensus of $79.92 million.

For earnings history and earnings-related data on Twist Bioscience Corporation (TWST) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Ishares Msci South Korea Capped Etf (EWY) call put ratio 1 call to 1.5 puts as share price down 9.3%
• Rigetti Computing (RGTI) call put ratio 10.4 calls to 1 put with a focus on June 26 weekly 25 calls as share price up 2.8%